Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Clearside Biomedical, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 53
- −6 vs. Q1 2022
- Shares held
- 13.7M
- −2.63M (−16.1%) vs. Q1 2022
- Total value
- $20.1M
- −$17.3M (−46.2%) vs. Q1 2022
- New holders
- 4
- 9 more added
- Sold out
- 10
- 25 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLSD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $3.26K |
| Q1 2026 | 1 | $7.87K |
| Q4 2025 | 1 | $19.1K |
| Q3 2025 | 26 | $2.18M |
| Q2 2025 | 45 | $7.51M |
| Q1 2025 | 44 | $8.09M |
| Q4 2024 | 44 | $8.97M |
| Q3 2024 | 49 | $12.7M |
| Q2 2024 | 49 | $17.9M |
| Q1 2024 | 52 | $23.8M |
| Q4 2023 | 48 | $9.06M |
| Q3 2023 | 46 | $6.82M |
| Q2 2023 | 54 | $9.62M |
| Q1 2023 | 51 | $9.09M |
| Q4 2022 | 53 | $10.2M |
| Q3 2022 | 54 | $13.6M |
| Q2 2022 | 53 | $20.1M |
| Q1 2022 | 60 | $37.5M |
| Q4 2021 | 67 | $57.8M |
| Q3 2021 | 66 | $121.5M |
| Q2 2021 | 53 | $95.8M |
| Q1 2021 | 52 | $43.8M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Clearside Biomedical, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 440 | $0 | 0.00% | −3,004−87.2% | Reduced |
| Wells Fargo & Company | 388 | $0 | 0.00% | +338+676.0% | Added |
| Investors Asset Management of Georgia Inc | 250 | $0 | 0.00% | +250 | New |
| Tower Research Capital LLC (TRC) | 677 | $1.00K | 0.00% | −7,642−91.9% | Reduced |
| Citigroup Inc | 918 | $1.00K | 0.00% | −935−50.5% | Reduced |
| Cutler Group LP | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 4,400 | $6.00K | 0.00% | +4,300+4,300.0% | Added |
| The PNC Financial Services Group, Inc. | 5,586 | $8.00K | 0.00% | 00.0% | Unchanged |
| Merit Financial Group, LLC | 11,000 | $16.0K | 0.00% | +11,000 | New |
| Advisor Group Holdings, Inc. | 12,350 | $18.0K | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 12,780 | $19.0K | 0.00% | +12,780 | New |
| BNP Paribas Arbitrage, SA | 13,712 | $20.2K | 0.00% | −911−6.2% | Reduced |
| Private Advisor Group, LLC | 14,900 | $22.0K | 0.00% | −7,000−32.0% | Reduced |
| Citadel Advisors LLC | 15,266 | $23.0K | 0.00% | −15,873−51.0% | Reduced |
| Stifel Financial Corp | 15,730 | $23.0K | 0.00% | −1,750−10.0% | Reduced |
| Integrated Advisors Network LLC | 15,700 | $23.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 18,161 | $27.0K | 0.00% | +9,109+100.6% | Added |
| Algert Global LLC | 19,300 | $28.0K | 0.00% | +3,890+25.2% | Added |
| Charles Schwab Investment Management Inc | 20,216 | $30.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 21,127 | $31.0K | 0.00% | −15,219−41.9% | Reduced |
| Ameritas Advisory Services, LLC | 20,810 | $31.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 22,648 | $33.0K | 0.00% | −1,200−5.0% | Reduced |
| Price T Rowe Associates Inc | 23,200 | $34.0K | 0.00% | 00.0% | Unchanged |
| Curi Capital | 25,000 | $37.0K | 0.01% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 26,000 | $38.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 26,461 | $38.0K | 0.00% | +18,264+222.8% | Added |
| Bank of New York Mellon Corp | 29,519 | $43.0K | 0.00% | −1,276−4.1% | Reduced |
| Mackenzie Financial Corp | 33,448 | $49.0K | 0.00% | +21,691+184.5% | Added |
| Acadian Asset Management LLC | 35,333 | $51.0K | 0.00% | +35,333 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 50,029 | $74.0K | 0.00% | −29,223−36.9% | Reduced |
| Northeast Financial Consultants Inc | 53,000 | $78.0K | 0.01% | 00.0% | Unchanged |
| Signaturefd, LLC | 54,177 | $80.0K | 0.00% | 00.0% | Unchanged |
| Synovus Financial Corp | 64,851 | $95.0K | 0.00% | −10,000−13.4% | Reduced |
| Franklin Resources Inc | 76,041 | $112.0K | 0.00% | −35,572−31.9% | Reduced |
| Bank of America Corp | 77,263 | $113.0K | 0.00% | −43,237−35.9% | Reduced |
| Northern Trust Corp | 88,961 | $131.0K | 0.00% | −7,845−8.1% | Reduced |
| Gsa Capital Partners LLP | 98,097 | $144.0K | 0.02% | +19,823+25.3% | Added |
| Susquehanna International Group, LLP | 167,410 | $246.0K | 0.00% | +63,572+61.2% | Added |
| First Manhattan Co | 175,000 | $257.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 193,363 | $284.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 211,885 | $311.0K | 0.00% | −122,615−36.7% | Reduced |
| Marshall Wace, LLP | 217,815 | $321.0K | 0.00% | −194,216−47.1% | Reduced |
| Millennium Management LLC | 305,720 | $449.0K | 0.00% | −755,195−71.2% | Reduced |
| Bridgeway Capital Management, LLC | 316,600 | $465.0K | 0.01% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 361,900 | $532.0K | 0.00% | −296,400−45.0% | Reduced |
| Geode Capital Management, LLC | 523,991 | $770.0K | 0.00% | +34,062+7.0% | Added |
| Morgan Stanley | 601,732 | $885.0K | 0.00% | −540,108−47.3% | Reduced |
| Assenagon Asset Management S.A. | 756,200 | $1.11M | 0.00% | −157,589−17.2% | Reduced |
| Renaissance Technologies LLC | 807,789 | $1.19M | 0.00% | −57,162−6.6% | Reduced |
| BlackRock Inc. | 1,212,993 | $1.78M | 0.00% | −6,174−0.5% | Reduced |
| Vanguard Group Inc | 2,165,677 | $3.18M | 0.00% | 00.0% | Unchanged |
| ACT Capital Management, LLC | 2,288,200 | $3.36M | 4.70% | −170,400−6.9% | Reduced |
| Carmignac Gestion | 2,390,344 | $3.51M | 0.07% | −95,308−3.8% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −86,216−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −50,947−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −45,373−100.0% | Sold out |
| Newman Dignan & Sheerar, Inc. | 0 | $0 | 0.00% | −27,023−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −25,600−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −21,652−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −19,200−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −15,500−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −1,165−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −380−100.0% | Sold out |
| Golden State Equity Partners | – | – | – | – | Not filed |